SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-123971
Filing Date
2022-04-27
Accepted
2022-04-27 17:25:02
Documents
6
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d297791ddef14a.htm DEF 14A 418115
2 GRAPHIC g297791g06y13.jpg GRAPHIC 209528
3 GRAPHIC g297791g07v97.jpg GRAPHIC 232284
4 GRAPHIC g297791g08h41.jpg GRAPHIC 23601
5 GRAPHIC g297791g25h31.jpg GRAPHIC 35250
6 GRAPHIC g297791g48i45.jpg GRAPHIC 57288
  Complete submission text file 0001193125-22-123971.txt   1188331
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39045 | Film No.: 22861078
SIC: 2834 Pharmaceutical Preparations